Dr. Yun Shen from Pennington Biomedical Research Center will lead a team to explore the use of AI for precision hypertension management in diabetes care of Type-2. The research is funded by a prize of $ 250,000 from the collaboration in action program, founded by Championship Health Partners LSU and Our Lady of the Lake Health.
Hypertension is a comorbidity present in 85 percent of patients with type-2 diabetes, which leads to a significant increase in the risk of cardiovascular problems. The research project, “Use AI for precision hypertension management: promoting treatment paradigms in type 2 diabetes care”, will investigate a large collection of anonymized data from the electronic health files of Our Lady of the Lake Health for type 2 diabetes.
Researchers will apply this data to an artificial decision -based decision -making system, which will help interpret the data and to guide the personalized dosage and treatments of the medicine. The goal is improved blood pressure control, reduced cardiovascular risks and improved quality of life for patients.
Regulating blood pressure is a key factor in reducing diabetic complications. By supervising the AI’s analysis of this data brove, we will not only get a better understanding of the range of type-2 diabetes, but also how they can best treat ideal medication dosing and additional care. I am proud to go to my colleagues at LSU in this endeavor. ”
Dr. Yun Shen, university teacher chronic disease pidemiology research at Pennington Biomedical
The cooperation in the action program is an attempt to strengthen ties in the research community, which improves cooperation between researchers from Pennington Biomedical Research Center, LSU, Our Lady of the Lake Health and other partners. In September 2024, the collaboration in the action program announced an investment of $ 1.2 million to support five collaborative LSU teams that will follow fundamental, clinical and translational research in five critical areas: cardiovascular disease and care; Extensive cancer care; trauma and neuroscience; chronic respiratory disease; and sports medicine and performance. The AI for type 2 diabetic project led by Dr. Shen is one of the last two recipients awarded for the inaugural round.
“The intellectual capital, research capacity and world -class facilities in Baton Rouge and South Louisiana are ripe for the type of collaboration that is promoted in the collaborative program,” Dr. John Kirwan, executive director of Pennington Biomedical. “I congratulate Dr. Shen and his colleagues, both here at Pennington Biomedical and elsewhere, while they are starting this innovative approach, applying advanced artificial intelligence technology to a problem that influences type 2 diabetes everywhere. Collaboration attractions such as this RAS thinking and innovative discoveries.”
In the spirit of the cooperation research approach, Dr. Cooperation with colleagues from different organizations, including Dr. Shuangqing Wei from LSU, Dr. Ibrahim Musa Yola from LSU Health New Orleans and Drs. Tiffany Wesley Ardoin, Tonya Jagnaux and Jolene Johnson from Franciscan Missionaries of Our Lady Health System/LSU Health New Orleans. Drs. Gang Hu and Ronald Horswell, as well as San Chu from Pennington Biomedical, also work together on the project.
“I am very happy to be part of such a diverse and strong interdisciplinary team,” said Dr. Shuangquing Wei, Professor and chairman of the Electrical & Computer Engineering Division of the LSU College of Engineering. “I am also grateful for the generous support via this pilot program, which will enable us to develop tailor -made algorithms that are designed to help type 2 diabetes patients to manage their blood pressure more effectively. The application of AI techniques in health care has been given enormous interest, and I am enthusiastic to contribute.”
“I am pleased to work with this exceptional team to use artificial intelligence in tackling the urgent health challenges that our community is confronted with,” Dr. Tonya Jagnaux, Chief Medical Informatics Officer and Chief Medical Analytics Officer at Our Lady of the Lake Regional Medical Center. “By integrating AI-driven insights, we have a unique opportunity to refine treatment strategies, improve the results of the patient and tackle inequalities in health care. This research is an important step in the direction of promoting precision medicine and improving care for people with type 2 diabetes and hypertensionia.”